# Regeneron Pharmaceuticals, Inc. (REGN) — Q1-2011 Earnings Results

**Report date:** 2011-05-03 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q1-2011

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Misses on EPS, Stock Down 4.84%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.49 | N/A | -27.94% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about recent performance but remains committed to future strategies. They did not provide specific guidance for upcoming quarters.

**Key quotes:**

> Management acknowledged the challenges faced this quarter.

> They emphasized a focus on long-term growth despite current setbacks.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Regeneron Pharmaceuticals faced challenges this quarter, particularly reflected in the negative EPS. The stock dropped 4.84% in reaction to the disappointing earnings, signaling investor concern. Without guidance, uncertainty remains about the company's near-term performance and strategy.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q1-2011_